Methamphetamine-induced changes in the striatal dopamine pathway in -opioid receptor knockout mice

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Park, Sang Won ^a   Shen, Xine ^b   Tien, Lu Tai ^c   Roman, Richard ^a   Ma, Tangeng ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b SOOCHOW UNIVERSITY   (China)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

opioid receptor; addiction; Amphetamine; dopamine receptors

Indexed keywords

DOPAMINE 1 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; METHAMPHETAMINE; MU OPIATE RECEPTOR; RGS2 PROTEIN; RGS4 PROTEIN; DOPAMINE; RGS PROTEIN; RGS2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORPUS STRIATUM; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; SIGNAL TRANSDUCTION; STEREOTYPY; STRIATE CORTEX; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; CENTRAL NERVOUS SYSTEM SENSITIZATION; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE MUTANT;

ANIMALIA; MUS;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM SENSITIZATION; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNITS; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, DOPAMINE D1; RECEPTORS, OPIOID, MU; RGS PROTEINS; STEREOTYPED BEHAVIOR;

EID: 81055127634     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-83     Document Type: Article

References (63)

1. Communities across the country are trying to respond to increased abuse of methamphetamine, a powerfully addictive stimulant. Volkow ND, NIDA webpage: message from the Director on Methamphetamine abuse 2005 http://www.nida.nih.gov/ about/welcome/messagemeth405.html
2. Methamphetamine abuse, HIV infection, and neurotoxicity. Reiner BC, Keblesh JP, Xiong H, Int J Physiol Pathophysiol Pharmacol 2009 25 162 179
3. Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. Shippenberg TS, Heidbreder C, J Pharmacol Exp Ther 1995 273 808 815 7752084
4. Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability? Bartlett E, Hallin A, Chapman B, Angrist B, Neuropsychopharmacology 1997 16 77 82 10.1016/S0893- 133X(96)00164-9 8981391 (Pubitemid 27030998)
5. Drug Wanting: Behavioral Sensitization and Relapse to Drug-Seeking Behavior. Steketee JD, Kalivas PW, Pharmacol Rev 2011 63 R
6. The neural basis of drug craving: an incentive-sensitization theory of addiction. Robinson TE, Berridge KC, Brain Res Brain Res Rev 1993 18 247 291 8401595 (Pubitemid 23219500)
7. The psychology and neurobiology of addiction: an incentive-sensitization view. Robinson TE, Berridge KC, Addiction 2000 95 Suppl 2 91 117 11002906
8. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine. Itzhak Y, Martin JL, Ali SF, Prog Neuropsychopharmacol Biol Psychiatry 2002 26 1177 1183 10.1016/S0278-5846(02) 00257-9 12452543 (Pubitemid 35256113)
9. In Chemical Neuroanatomy: Classical Transmitters in the CNS, Part 1. Bjorklund A, Lindvall O, Elsevier, Amsterdam, Bjorklund A, Lindvall, 1984 55 122
10. Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Kelley AE, Christopher GL, Gauthier AM, Psychopharmacology 1988 95 556 559 3145527
11. D1/D2 dopamine receptor interactions in basal ganglia functions. In the dopamine receptors. Marshall JF, Ruskin DN, LaHoste GJ, New Jersey: Humana Press, Neve KA, Neve RL, 1997 193 219
12. Dose-dependent response of central dopaminergic systems to buspirone in mice. Jadhav SA, Gaikwad RV, Gaonkar RK, Thorat VM, Gursale SC, Balsara JJ, Indian J Exp Biol 2008 46 704 714 19024168
13. The physiology, signaling, and pharmacology of dopamine receptors. Beaulieu J, Gainetdinov RR, Pharmacol Rev 2011 63 182 217 10.1124/pr.110.002642 21303898
14. There RGS proteins have a signaling complex; interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. Abramow-Newerly M, Roy AA, Nunn C, Chidiac P, Cell Signal 2006 18 579 591 10.1016/j.cellsig.2005.08.010 16226429 (Pubitemid 43113289)
15. Psychostimulants, madness, memory, and RGS proteins? Burchett SA, Neuromol Med 2005 7 101 127 10.1385/NMM:7:1-2:101 (Pubitemid 41278192)
16. Regulator of G-protein signaling 4 interacts with metabotropic glutamate receptor subtype 5 in rat striatum: relevance to amphetamine behavioral sensitization. Schwendt M, McGinty JF, J Pharmacol Exper Therap 2007 323 650 657 10.1124/jpet.107.128561 (Pubitemid 350005138)
17. Behavioral effects of chronic exposure to selective D1 and D2 dopamine receptor agonists. Braun AR, Chase TN, Eur J Pharmacol 1988 147 441 451 10.1016/0014-2999(88)90179-3 3259931 (Pubitemid 18076505)
18. Repeated stimulation of D1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion. Rouillard C, Bedard P, Falardeau P, DiPaolo T, Eur J Pharmacol 1988 157 125 133 10.1016/0014-2999(88) 90375-5 2975996
19. Enhanced stereotypic behavior by chronic treatment with bromocriptine accompanies increase of D1 receptor binding. Xiao-Da Z, Guo-Zhang J, Life Sci 1988 42 1841 1845 10.1016/0024-3205(88)90022-7 2966885
20. Differential effect of repeated treatment with L-dopa on dopamine-D1 or D2 receptors. Parenti M, Flauto C, Parati E, Vescovi A, Groppetti A, Neuropharmacology 1986 25 331 334 10.1016/0028-3908(86)90261-3 2871516 (Pubitemid 16165434)
21. Reward processing by the opioid system in the brain. Le Merrer J, Becker JA, Befort K, Kieffer BL, Physiol Rev 2009 89 1379 1412 10.1152/physrev.00005. 2009 19789384
22. Naloxone blockade of amphetamine place preference conditioning. Trujillo KA, Belluzzi JD, Stein L, Psychopharmacology (Berlin) 1991 104 265 274 10.1007/BF02244190
23. Neuroanatomical sites mediating the motivational effects of opioids as mapped by conditioned place preference paradigm in rats. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS, J Pharmacol Exp Ther 1993 264 489 495 8093731 (Pubitemid 23309241)
24. The role of the delta-opioid receptor subtypes in cocaine and methamphetamine induced place preferences. Suzuki T, Mori T, Tsuji M, Misawa M, Nagase H, Life Sci 1994 55 339 L344
25. Molecular biology and pharmacology of cloned opioid receptors. Knapp RJ, Malatynska E, Collins N, Fang L, Wang JY, Hruby VJ, Roeske WR, Yamamura HI, The FASEB J 1995 9 516 525
26. Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced up-regulation of zif/268 mRNA expression in rat forebrain. Wang JQ, McGinty JF, J Neurochem 1995 65 2706 2715 7595569 (Pubitemid 3002928)
27. Role of endogenous enkephalin and dynorphin in amphetamine induced behavioral sensitization [abstract]. Hodler C, Paquet B, Gilbert F, Drolet G, Levesque D, Rouillard C, Society of Neuroscience 35th Annual Meeting, Washington, DC 2005 1029.7
28. mu-Opioid receptor knockout mice are insensitive to methamphetamine- induced behavioral sensitization. Shen X, Purser C, Tien LT, Chiu CT, Paul IA, Baker R, Loh HH, Ho IK, Ma T, J Neurosci Res 2010 88 2294 2302 10.1002/jnr.22386 20209629
29. -opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF, Wei LN, Brain Res Mol Brain Res 1998 54 321 326 9555078 (Pubitemid 28171797)
30. Methamphetamine-induced expression of zif268 mRNA is prevented by haloperidol in mice lacking mu-opioid receptor. Tien L, Ho IK, Ma T, Neurotoxicology 2010 31 326 330 10.1016/j.neuro.2010.02.002 20184921
31. Substantia nigra and stereotyped behavior. Costall B, Naylor RJ, Olley JE, Eur J Pharmacol 1972 18 95 106 10.1016/0014-2999(72)90136-7 4555563
32. D1 and D2 dopamine receptor distribution in the neuroleptic nonresponsive and neuroleptic responsive lines of mice, a quantitative receptor autoradiographic study. Qian Y, Hitzemann B, Hitzemann R, J Pharmacol Exp Ther 1992 261 341 348 1532835
33. Dopamine D1 and D2 receptors in the forebrain of dystonia musculorum mutant mice: an autoradiographic survey in relation to dopamine contents. Ongali B, Ase AR, Hebert C, Amdiss F, Reader TA, Synapse 2000 37 1 15 10.1002/(SICI)1098-2396(200007)37:1<1::AID-SYN1>3.0.CO;2-9 10842346 (Pubitemid 30366496)
34. The effect of chronic morphine and cocaine administration on the Gs and Go protein messenger RNA levels in the rat hippocampus. Przewlocka B, Lason W, Przewlocki R, Neuroscienc 1994 63 1111 1116 10.1016/0306-4522(94)90576-2 (Pubitemid 24366159)
35. Rgs4 mRNA expression is decreased in the brain of Fmr1 knockout mouse. Tervonen T, Kerman K, Oostra BA, Castre'n M, Molecular Brain Research 2005 133 162 165 10.1016/j.molbrainres.2004.09.023 15661377 (Pubitemid 40127502)
36. Role of mu-opioid receptor in modulation of preproenkephalin mRNA expression and opioid and dopamine receptor binding in methamphetamine- sensitized mice. Tien LT, Ho IK, Loh HH, Ma T, J Neurosci Res 2007 85 673 680 10.1002/jnr.21145 17139685
37. The psychology and neurobiology of addiction: an incentive-sensitization view. Robinson TE, Berridge KC, Addiction 2000 95 Suppl 2 91 117 11002906
38. Methamphetamine-induced behavioral sensitization in mice: alterations in mu-opioid receptor. Chiu C, Ma T, Ho IK, J Biomedical Sci 2006 13 797 811 10.1007/s11373-006-9102-x (Pubitemid 44900652)
39. Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636. Lin CW, Bianchi BA, Miller TR, Stashko MA, Wang SS, Curzon P, Bednarz L, Asin KE, Britton DR, J Pharmacol Exper Therap 1996 276 1022 1029
40. Neural mechanisms of addiction: the role of reward-related learning and memory. Hyman SE, Malenka RC, Nestler EJ, Annu Rev Neurosci 2006 29 565 598 10.1146/annurev.neuro.29.051605.113009 16776597 (Pubitemid 44476856)
41. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, Sibley DR, Science 1990 250 1429 1432 10.1126/science.2147780 2147780 (Pubitemid 120031867)
42. Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation. Chatoff EH, Marck BT, Matsumoto AM, Dorsa DM, Palmiter RD, PNAS 2001 98 10451 10456 10.1073/pnas.181356498 11517332 (Pubitemid 32803040)
43. Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2-3 weeks. Tang F, Costa E, Schwarts JP, Proc Natl Acad Sci USA 1983 80 3841 3844 10.1073/pnas.80.12.3841 6190182 (Pubitemid 13063150)
44. Regulation of striatal enkephalin turnover in rats receiving antagonists of specific dopamine receptor subtypes. Mocchetti I, Naranjo JR, Costa E, J Pharmacol Exp Ther 1987 241 1120 1124 3110407
45. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HH, Niznik HB, Nature 1991 350 614 619 10.1038/350614a0 1826762 (Pubitemid 21912283)
46. GABA(B) receptors: altered coupling to G-proteins in rats sensitized to amphetamine. Zhang K, Tarazi FI, Campbell A, Baldessarini RJ, Neuroscience 2000 101 5 10 10.1016/S0306-4522(00)00344-4 11068131
47. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P, Mol Psychiatry 2001 6 293 301 10.1038/sj.mp.4000866 11326297 (Pubitemid 32275674)
48. Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. Young LT, Li PP, Kish SJ, Siu KP, Kamble A, Hornykiewicz O, Warsh JJ, J Neurochem 1993 61 890 898 10.1111/j.1471-4159.1993.tb03600.x 8395565 (Pubitemid 23241225)
49. Repeated reserpine increases striatal dopamine receptor and guanine nucleotide binding protein RNA. Butkerait P, Friedman E, J Neurochem 1993 60 566 571 10.1111/j.1471-4159.1993.tb03186.x 8419537 (Pubitemid 23030952)
50. Cellular regulation of RGS proteins: Modulators and integrators of G protein signaling. Hollinger S, Hepler JR, Pharmacol Rev 2002 54 527 559 10.1124/pr.54.3.527 12223533
51. ifamily G-proteins with differential selectivity and maximal activity. Hooks SB, Waldo GL, Krumins AM, Harden TK, JBC 2003 278 10087 10093 10.1074/jbc.M211382200 (Pubitemid 36800265)
52. GTPase-activating proteins (GAPs) for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Ross EM, Wilkie TM, Annu Rev Biochem 2000 69 795 827 10.1146/annurev.biochem.69.1.795 10966476
53. Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. Gold SJ, Ni YG, Dohlman HG, Nestler EJ, J Neurosci 1997 17 8024 8037 9315921 (Pubitemid 27426238)
54. Regional distribution of regulators of G-protein signaling (RGS) 1, 2, 13, 14, 16, and GAIP messenger ribonucleic acids by in situ hybridization in rat brain. Grafstein-Dunn E, Kathleen HY, Cockett MI, Khawaja XZ, Molecular Brain Research 2001 88 113 123 10.1016/S0169-328X(01)00038-9 11295237 (Pubitemid 32274265)
55. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: Clues for RGS2 and RGS4 functions. Taymans JM, Leysen JE, Langlois X, J Neurochem 2003 84 1118 1127 10.1046/j.1471-4159.2003. 01610.x 12603835 (Pubitemid 36330664)
56. RGS expression in rat striatum: modulation by dopamine receptors and effects of repeated amphetamine administration. Burchett SA, Bannon MJ, Grannenab JG, J Neurochem 1999 72 1529 1533 10098858 (Pubitemid 29140825)
57. Regulators of G protein signaling: rapid changes in mRNA abundance in response to amphetamine. Burchett SA, Volk ML, Bannon MJ, Granneman JG, J Neurochem 1998 70 2216 2219 9572311 (Pubitemid 28207849)
58. Abused drugs modulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment. Bishop GB, Cullinan WE, Curran E, Gustein HB, Neurobiol Dis 2002 10 334 343 10.1006/nbdi.2002.0518 12270694 (Pubitemid 35217585)
59. Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors. Schwendt M, Gold SJ, McGinty JF, J Neurochem 2006 96 1606 1615 10.1111/j.1471-4159.2006.03669.x 16539683 (Pubitemid 43351620)
60. Chronic cocaine reduces RGS4 mRNA in rat prefrontal cortex and dorsal striatum. Schwendt M, Hearing MC, See RE, McGinty JF, NeuroReport 2007 18 1261 1265 10.1097/WNR.0b013e328240507a 17632279 (Pubitemid 47075593)
61. Regulator of G-protein signaling 4 interacts with mGluR5 receptors in rat striatum: Relevance to amphetamine behavioral sensitization. Schwendt M, McGinty JF, J Pharmacol Exper Therap 2007 323 650 657 10.1124/jpet.107.128561 (Pubitemid 350005138)
62. Gene expression profile from the striatum of amphetamine-treated rats: a cDNA array and in situ hybridization histochemical study. Gonzalez-Nicolini V, McGinty JF, Gene Expr Patterns 2002 1 193 198 10.1016/S1567-133X(02)00017-0
63. (Pubitemid 46238037)